Though the FDA may claim it would have had to have read off hundreds of disclosures to cover everyone on the panel, it is those related to Merck and Pfizer that are likely to raise eyebrows.
Now that the claim construction's complete, next on the docket is the ITC's evidentiary hearing (read: trial) starting May 31st, and afterwards we'll finally get the ITC's decision.